Cargando…
Mucosal vaccination with a live recombinant rhinovirus followed by intradermal DNA administration elicits potent and protective HIV-specific immune responses
Mucosal immunity is deemed crucial to control sexual transmission of human immunodeficiency virus (HIV). Herein we report the efficacy of a mucosal HIV vaccine strategy comprising intranasal (IN) vaccination with a cocktail of live recombinant human rhinoviruses (HRVs) encoding overlapping fragments...
Autores principales: | Tomusange, Khamis, Wijesundara, Danushka, Gummow, Jason, Wesselingh, Steve, Suhrbier, Andreas, Gowans, Eric J., Grubor-Bauk, Branka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5113119/ https://www.ncbi.nlm.nih.gov/pubmed/27853256 http://dx.doi.org/10.1038/srep36658 |
Ejemplares similares
-
A HIV-Tat/C4-binding protein chimera encoded by a DNA vaccine is highly immunogenic and contains acute EcoHIV infection in mice
por: Tomusange, Khamis, et al.
Publicado: (2016) -
Emerging Targets for Developing T Cell-Mediated Vaccines for Human Immunodeficiency Virus (HIV)-1
por: Wijesundara, Danushka K., et al.
Publicado: (2017) -
Preclinical Development and Production of Virus-Like Particles As Vaccine Candidates for Hepatitis C
por: Masavuli, Makutiro Ghislain, et al.
Publicado: (2017) -
Safety Profile of a Multi-Antigenic DNA Vaccine Against Hepatitis C Virus
por: Gummow, Jason, et al.
Publicado: (2020) -
Increase in DNA vaccine efficacy by virosome delivery and co-expression of a cytolytic protein
por: Gargett, Tessa, et al.
Publicado: (2014)